Please login to the form below

Not currently logged in
Email:
Password:

Dr Jan van de Winkel joins Austrian biotech Hookipa

Joins the firm's board of directors, taking up the chairman's role

Dr Van De WinkelAustrian biotech Hookipa has appointed its chairman of the board of directors in the form of Dr Jan van de Winkel.

Current president and chief executive officer of Genmab, Dr van de Winkel joins the board with over 25 years’ experience in the therapeutic antibody field.

He said: “I am honoured to take on the role of chairman at this exciting time in the life of this very promising company and I am looking forward to building the company together with its management team and other board members who have done this very successfully before.”

Dr van de Winkel’s career experience has seen him serve Medarex Europe as its vice president and scientific director before co-founding Genmab.

Jorn Aldag, chief executive officer, Hookipa, said: “We are proud to have attracted Jan to join our board of directors as Chairman.

“As Hookipa grows and progresses to become an integrated biotech company with multiple clinical programmes in infectious diseases and immune-oncology, Jan’s experience of building companies and his scientific insight will prove invaluable.”

7th November 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics